On average, it takes 17 years before new innovation is disseminated into clinical practice. How can cardiothoracic surgery change that statistic and speed up the process?
On average, it takes 17 years before new innovation is disseminated into clinical practice. How can cardiothoracic surgery change that statistic and speed up the process? Juan A. Sanchez, MD (St. Agnes HealthCare Baltimore) moderates a discussion with Michael S.
The volumes of two aortic valve replacements (AVR) procedures have changed dramatically over the past few years, with more transcatheter procedures now being performed than open surgical procedures. Four cardiac surgeons discuss the evolving trends in TAVR, why the changes are occurring, and what’s ahead for TAVR and SAVR. Wilson Y. Szeto, MD moderates the discussion that also features Michael J. Mack, MD, John V. Conte, MD, and Thomas E. MacGillivray, MD.
Should patients remain active before, during, and after cardiac surgery? Some surgeons have opposing views. Thomas G. Gleason, MD, from the University of Pittsburgh, and Edward P. Chen, MD, from Emory University, discuss the role of exercise in the treatment and recovery process following surgery for various forms of heart disease, especially among active patients.
Four leading experts discuss how catheter-based techniques will re-emulate the gold standard for mitral valve surgery, the important role of 3D Echo technology, the need for transseptal puncture skills, and navigating the local politics.
For surgeons beginning academic careers, developing a research portfolio is frequently a key metric of success. Yet many have significant concerns about finding adequate funding in an era where National Institutes of Health (NIH) funding is at an all-time low. However, early career investigators have a number of advantages, even in a competitive research climate.
